L. Bulteau-Pignoux

Activation of G551D CFTR channel with MPB-91: regulation by ATPase activity and phosphorylation.

L. D. Howell, R. Dérand, J. Cohn, 2001, American journal of physiology. Cell physiology.

Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells.

L. Galietta, R. Dérand, J. Vierfond, 2001, Journal of cell science.

Activation of VPAC1 receptors by VIP and PACAP‐27 in human bronchial epithelial cells induces CFTR‐dependent chloride secretion

R. Dérand, J. Muller, Alicia Montoni, 2004, British journal of pharmacology.

Determination of CFTR chloride channel activity and pharmacology using radiotracer flux methods.

J. Riordan, R. Dérand, G. Heda, 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Synthesis, SAR, crystal structure, and biological evaluation of benzoquinoliziniums as activators of wild-type and mutant cystic fibrosis transmembrane conductance regulator channels.

R. Dérand, G. Morgant, J. Vierfond, 2004, Journal of medicinal chemistry.

The Cystic Fibrosis Mutation G551D Alters the Non-Michaelis-Menten Behavior of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channel and Abolishes the Inhibitory Genistein Binding Site*

R. Dérand, F. Becq, L. Bulteau-Pignoux, 2002, Journal of Biological Chemistry.

Comparative Pharmacology of the Activity of Wild-type and G551D Mutated CFTR Chloride Channel: Effect of the Benzimidazolone Derivative NS004

R. Dérand, F. Becq, L. Bulteau-Pignoux, 2003, The Journal of Membrane Biology.

Genistein Modifies the Activation Kinetics and Magnitude of Phosphorylated Wild-Type and G551D-CFTR Chloride Currents

R. Dérand, F. Becq, M. Joffre, 2002, Journal of Membrane Biology.